Isabelle Cremer

11.3k citations

89 papers · 7.4k indexed · 2 hit papers · h-index 47

Immunology top 0.2%
Oncology top 0.5%
Molecular Biology top 5%
Pulmonary and Respiratory Medicine top 2%
Epidemiology top 5%

Co-authors: Catherine Sautès‐Fridman Wolf H. Fridman Diane Damotte Marie‐Caroline Dieu‐Nosjean Marco Alifano Guido Kroemer Jérôme Galon Lorenzo Galluzzi
Topics: Immune Cell Function and Interaction (39 papers)Cancer Immunotherapy and Biomarkers (30 papers)Immunotherapy and Immune Responses (26 papers)
Cited by: Immunology Oncology Cancer Research
Journals: Proceedings of the National Academy of Sciences Journal of Clinical Investigation Journal of Clinical Oncology
Partner nations: France Czechia United States

In The Last Decade

Isabelle Cremer

87 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer

2014 598 citations Claire Germain, Sacha Gnjatic et al. American Journal of Respiratory and Critical Care Medicine profile →
Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T Cells

2013 500 citations Jérémy Goc, Claire Germain et al. Cancer Research profile →

Peers

Countries citing papers authored by Isabelle Cremer

Since Specialization

Citations

This map shows the geographic impact of Isabelle Cremer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Cremer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Cremer more than expected).

Fields of papers citing papers by Isabelle Cremer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Cremer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Cremer. The network helps show where Isabelle Cremer may publish in the future.

Co-authorship network of co-authors of Isabelle Cremer

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Cremer. A scholar is included among the top collaborators of Isabelle Cremer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Cremer. Isabelle Cremer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death 2019 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Lenka Kašíková,Iva Truxová,Isabelle Cremer,Catherine Sautès‐Fridman,Oliver Kepp,Guido Kroemer,Radek Špíšek,Jitka Fučíková	3
2	Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung Tumors 2019 ·Journal of Thoracic Oncology ·Audrey Mansuet‐Lupo,Marc Barritault,Marco Alifano,(unknown),(unknown),Jérôme Biton,(unknown),(unknown),Isabelle Cremer,Jean‐François Régnard,Ludovic Fournel,Bastien Rance,Marie Wislez,Pierre Laurent‐Puig,Ronald Herbst,Diane Damotte,Hélène Blons	59
3	TP53, STK11 , and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma 2018 ·Clinical Cancer Research ·Jérôme Biton,Audrey Mansuet‐Lupo,Nicolas Pécuchet,Marco Alifano,Hanane Ouakrim,Jennifer Arrondeau,Pascaline Boudou‐Rouquette,François Goldwasser,Karen Leroy,Jérémy Goc,Marie Wislez,Claire Germain,Pierre Laurent‐Puig,Marie‐Caroline Dieu‐Nosjean,Isabelle Cremer,Ronald Herbst,Hélène Blons,Diane Damotte	251
4	Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells 2018 ·OncoImmunology ·(unknown),Kristina Iribarren,Florent Petitprez,Solenne Marmier,Audrey Lupo,(unknown),Hanane Ouakrim,(unknown),Vincenzo Di Bartolo,Pierre-Emmanuel Joubert,Oliver Kepp,Guido Kroemer,Marco Alifano,Diane Damotte,Isabelle Cremer	36
5	Biomarqueurs prédictifs de l’immunothérapie anti-PD1/PD-L1 dans le cancer broncho-pulmonaire non à petites cellules 2018 ·Revue de Pneumologie Clinique ·Audrey Lupo,Marco Alifano,Marie Wislez,(unknown),(unknown),Jérôme Biton,Isabelle Cremer,François Goldwasser,Karen Leroy,Diane Damotte	5
6	Intratumoral Immune Cell Densities Are Associated with Lung Adenocarcinoma Gene Alterations 2016 ·American Journal of Respiratory and Critical Care Medicine ·Audrey Mansuet‐Lupo,Marco Alifano,Nicolas Pécuchet,Jérôme Biton,Étienne Becht,Jérémy Goc,Claire Germain,Hanane Ouakrim,Jean‐François Régnard,Isabelle Cremer,Pierre Laurent‐Puig,Marie‐Caroline Dieu‐Nosjean,Hélène Blons,Diane Damotte	49
7	Trial watch: Naked and vectored DNA-based anticancer vaccines 2015 ·OncoImmunology ·Norma Bloy,Aitziber Buqué,Fernando Aranda,Francesca Castoldi,Alexander Eggermont,Isabelle Cremer,Catherine Sautès‐Fridman,Jitka Fučíková,Jérôme Galon,Radek Špíšek,Éric Tartour,Laurence Zitvogel,Guido Kroemer,Lorenzo Galluzzi	32
8	Trial watch: Tumor-targeting monoclonal antibodies for oncological indications 2015 ·OncoImmunology ·Erika Vacchelli,Jonathan Pol,Norma Bloy,Alexander Eggermont,Isabelle Cremer,Wolf H. Fridman,Jérôme Galon,Aurélien Marabelle,Holbrook E. Kohrt,Laurence Zitvogel,Guido Kroemer,Lorenzo Galluzzi	40
9	Trial Watch—Immunostimulation with cytokines in cancer therapy 2015 ·OncoImmunology ·Erika Vacchelli,Fernando Aranda,Norma Bloy,Aitziber Buqué,Isabelle Cremer,Alexander Eggermont,Wolf H. Fridman,Jitka Fučíková,Jérôme Galon,Radek Špíšek,Laurence Zitvogel,Guido Kroemer,Lorenzo Galluzzi	44
10	TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non–Small Cell Lung Cancer 2014 ·Cancer Research ·(unknown),Lucile Crozet,Diane Damotte,Kristina Iribarren,Catherine Schramm,Marco Alifano,Audrey Lupo,Julien Cherfils‐Vicini,Jérémy Goc,Sandrine Katsahian,(unknown),Marie‐Caroline Dieu‐Nosjean,Wolf H. Fridman,Catherine Sautès‐Fridman,Isabelle Cremer	88
11	Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancerbreakdown → 2014 ·American Journal of Respiratory and Critical Care Medicine ·Claire Germain,Sacha Gnjatic,Fella Tamzalit,Samantha Knockaert,Romain Remark,Jérémy Goc,Alice Lepelley,Étienne Becht,Sandrine Katsahian,Geoffray Bizouard,Pierre Validire,Diane Damotte,Marco Alifano,Pierre Magdeleinat,Isabelle Cremer,Jean‐Luc Teillaud,Wolf H. Fridman,Catherine Sautès‐Fridman,Marie‐Caroline Dieu‐Nosjean	598
12	Mature Cytotoxic CD56bright/CD16 + Natural Killer Cells Can Infiltrate Lymph Nodes Adjacent to Metastatic Melanoma 2013 ·Cancer Research ·Meriem Messaoudene,Giulia Fregni,(unknown),J. Chanal,E. Maubec,(unknown),Benoît Couturaud,Angélique Girod,Xavier Sastre‐Garau,Sébastien Albert,C Guédon,Lydia Deschamps,Délphine Mitilian,Isabelle Cremer,Nicolas Jacquelot,Sylvie Rusakiewicz,Laurence Zitvogel,Marie‐Françoise Avril,Anne Caignard	79
13	Dendritic Cells in Tumor-Associated Tertiary Lymphoid Structures Signal a Th1 Cytotoxic Immune Contexture and License the Positive Prognostic Value of Infiltrating CD8+ T Cellsbreakdown → 2013 ·Cancer Research ·Jérémy Goc,Claire Germain,Thi Kim Duy Vo-Bourgais,Audrey Lupo,Christophe Klein,Samantha Knockaert,Luc de Chaisemartin,Hanane Ouakrim,Étienne Becht,Marco Alifano,Pierre Validire,Romain Remark,Scott A. Hammond,Isabelle Cremer,Diane Damotte,Wolf H. Fridman,Catherine Sautès‐Fridman,Marie‐Caroline Dieu‐Nosjean	500
14	Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin 2013 ·Clinical Cancer Research ·Romain Remark,Marco Alifano,Isabelle Cremer,Audrey Lupo,Marie‐Caroline Dieu‐Nosjean,Marc Riquet,Lucile Crozet,Hanane Ouakrim,Jérémy Goc,Aurélie Cazes,Jean–François Fléjou,Laure Gibault,Virginie Verkarre,Jean‐François Régnard,(unknown),Stéphane Oudard,Bernhard Mlecnik,Catherine Sautès‐Fridman,Wolf H. Fridman,Diane Damotte	284
15	Tumor microenvironment in NSCLC suppresses NK cells function 2012 ·OncoImmunology ·Isabelle Cremer,Wolf H. Fridman,Catherine Sautès‐Fridman	30
16	Characterization of Chemokines and Adhesion Molecules Associated with T cell Presence in Tertiary Lymphoid Structures in Human Lung Cancer 2011 ·Cancer Research ·Luc de Chaisemartin,Jérémy Goc,Diane Damotte,Pierre Validire,Pierre Magdeleinat,Marco Alifano,Isabelle Cremer,Wolf H. Fridman,Catherine Sautès‐Fridman,Marie‐Caroline Dieu‐Nosjean	252
17	Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma 2011 ·Cancer Research ·(unknown),Julien Cherfils‐Vicini,Diane Damotte,Lucile Crozet,Vincent Vieillard,Pierre Validire,Pascale André,Marie‐Caroline Dieu‐Nosjean,Marco Alifano,Jean‐François Régnard,Wolf H. Fridman,Catherine Sautès‐Fridman,Isabelle Cremer	381
18	Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity 2008 ·Genome biology ·Corneliu Hénégar,Joan Tordjman,Vincent Achard,Danièle Lacasa,Isabelle Cremer,Michèle Guerre-Millo,Christine Poitou,Arnaud Basdevant,Vladimír Štich,Nathalie Viguerie,Dominique Langin,Pierre Bédossa,Jean‐Daniel Zucker,Karine Clément	345
19	Mannose Receptor Ligand-Positive Cells Express the Metalloprotease Decysin in the B Cell Follicle 2001 ·The Journal of Immunology ·Christopher G. Mueller,Isabelle Cremer,Pierre Paulet,Shumpei Niida,Norihiko Maeda,(unknown),Wolf H. Fridman,Catherine Sautès‐Fridman	27
20	Retrovirally Mediated IFN-β Transduction of Macrophages Induces Resistance to HIV, Correlated with Up-Regulation of RANTES Production and Down-Regulation of C-C Chemokine Receptor-5 Expression 2000 ·The Journal of Immunology ·Isabelle Cremer,Vincent Vieillard,Edward De Maeyer	43

About Isabelle Cremer

Isabelle Cremer is a scholar working on Immunology, Oncology and Virology, having authored 89 papers that have together received 7.4k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (39 papers), Cancer Immunotherapy and Biomarkers (30 papers) and Immunotherapy and Immune Responses (26 papers). The work is most often cited by research in Immunology (4.5k citations), Oncology (3.9k citations) and Cancer Research (729 citations). Isabelle Cremer has collaborated with scholars based in France, Czechia and United States. Frequent co-authors include Catherine Sautès‐Fridman, Wolf H. Fridman, Diane Damotte, Marie‐Caroline Dieu‐Nosjean, Marco Alifano, Guido Kroemer, Jérôme Galon, Lorenzo Galluzzi, Jérémy Goc and Laurence Zitvogel. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact